Barinthus Biotherapeutics plc (BRNS) — Net Asset Momentum
Barinthus Biotherapeutics plc (BRNS) recorded a net asset momentum of -30.4% as of December 2024, with net assets of $130.13 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Barinthus Biotherapeutics plc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Barinthus Biotherapeutics plc Net Asset Momentum (2019–2024)
This chart tracks Barinthus Biotherapeutics plc's year-over-year net asset growth across 6 annual reporting periods from 2019 to 2024. The most recent momentum reading is -30.4%, with net assets of $130.13 Million USD as of December 2024. Read BRNS total debt and obligations for a breakdown of total debt and financial obligations.
Annual Net Asset History for Barinthus Biotherapeutics plc (2019–2024)
The table below shows the complete annual net asset history for Barinthus Biotherapeutics plc from 2019 to 2024, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Barinthus Biotherapeutics plc market capitalisation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $130.13 Million | $160.33 Million | $30.19 Million | ▼ -30.4% |
| 2023 | $187.00 Million | $214.51 Million | $27.51 Million | ▼ -23.1% |
| 2022 | $243.20 Million | $270.20 Million | $27.00 Million | ▼ -3.7% |
| 2021 | $252.56 Million | $280.71 Million | $28.15 Million | ▲ +8125.5% |
| 2020 | $-3.15 Million | $50.67 Million | $53.81 Million | ▲ +85.7% |
| 2019 | $-22.08 Million | $19.04 Million | $41.12 Million | — |